A total of 17 contenders will square off. The first debate with seven candidates will start at 5 p.m. Eastern time on Fox News Channel followed by a prime time debate at 9 p.m. with the top 10 candidates. The latter debate is set to go for two hours. All eyes will likely be on Donald Trump. Other Republican candidates include Jeb Bush, Ted Cruz, and Chris Christie.
Also, some of the major companies are reporting their latest quarterly earnings tomorrow. It's a mixture of several different companies from pharmaceutical to mass media.
Before the market opens, global pharmaceutical company Allergan (AGN) - Get Allergan plc Report, electric power company Duke Energy (DUK) - Get Duke Energy Corporation (DUK) Report, and mass media company Viacom (VIAB) - Get Viacom Inc. Class B Report are all reporting their earnings.
Also, 3D Systems (DDD) - Get 3D Systems Corporation Report and Orbitz Worldwide (OWW) will also report their earnings. Then, after the closing bell, energy drink manufacturer Monster Beverage (MNST) - Get Monster Beverage Corporation (MNST) Report, oil giant Petrobras (PBR) - Get Petroleo Brasileiro SA Sponsored ADR Report, entertainment company Lions Gate Entertainment (LGF) , and Overstock.com (OSTK) - Get Overstock.com, Inc. Report are all reporting their numbers as well.
But the company that's getting all the attention is Allergan. Allergan develops, manufactures, and distributes generic, branded, and over-the-counter pharmaceutical products.
For the second quarter of 2015, analysts are forecasting the company to report earnings of $4.38 a share on revenue of $5.71 billion.
The deal had originally been for 80% cash and 20% in stock but the company said this morning that it's going to pay all cash for the deal.
TheStreet's Jim Cramer is watching this company. Allergan is one of the stocks in Cramer's charitable trust portfolio, Action Alerts PLUS.
He says that Allergan's deal withTeva Pharmaceutical (TEVA) - Get Teva Pharmaceutical Industries Limited Sponsored ADR Report was a "brilliant idea." Allergan sold its generics business to Israel's Teva Pharmaceutical for $40.5 billion in cash and stock. This deal made Teva the largest producer of generics in the world.
At 8:30 a.m., the U.S. Labor Department will report weekly jobless claims.